Hepatitis b pediatric vaccine Disease Interactions
There are 2 disease interactions with hepatitis b pediatric vaccine:
Hepatitis B vaccine (Includes hepatitis b pediatric vaccine) ↔ hemophilia
Moderate Potential Hazard, Moderate plausibility. Applies to: Bleeding Associated with Coagulation Defect
Hepatitis B vaccine (adult and pediatric) is usually for intramuscular administration. However, it may be administered subcutaneously to persons at risk for hemorrhage following intramuscular injections (e.g., hemophiliacs), although it may result in lower antibody response. Additionally, when other aluminum- absorbed vaccines have been administered subcutaneously, an increased incidence of local reactions including subcutaneous nodules has been observed. Therefore, consider subcutaneous administration only in persons who are at risk of hemorrhage following intramuscular injections.
Hepatitis B vaccine (Includes hepatitis b pediatric vaccine) ↔ low birth weight
Moderate Potential Hazard, Moderate plausibility. Applies to: Prematurity/Underweight in Infancy
Hepatitis B vaccine should be deferred for infants with a birth weight less than 2,000 grams if the mother is documented to be HBsAg negative at the time of the infant's birth. If the mother is HBsAg positive (or the status cannot be determined), the infant should receive the vaccine within 12 hours after birth.
Apnea following intramuscular vaccination has been observed in some infants born prematurely and the decision to administer any intramuscular vaccine, including hepatitis B vaccine, should be based on consideration of the infant's medical status, and the potential benefits and risks of vaccination. Close monitoring is recommended.
Hepatitis b pediatric vaccine drug interactions
There are 202 drug interactions with hepatitis b pediatric vaccine
More about hepatitis b pediatric vaccine
- Hepatitis b pediatric vaccine Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- En Español
- Drug class: viral vaccines
Related treatment guides
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No information available.|
Do not stop taking any medications without consulting your healthcare provider.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.